On May 12, the conference “Long COVID: A Disabling Disease Awaiting Definition” was held at the Italian Senate in Rome. The event was organised on the initiative of Senator Andrea Crisanti in collaboration with the National Institute for Infectious Diseases “Lazzaro Spallanzani” in Rome and was attended by Professor Evelina Tacconelli, Chair of the Cohort
Next week, CCB members will be joining over 16,000 infectious disease and microbiology specialists at for the annual conference of the Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in Munich, Germany. ESCMID Global is one of the largest and the foremost congresses in the field of infection, bringing together >16,000 colleagues
Earlier this month, updates were made to the Central Data Repository (CDR), managed by the Cohort Coordination Board (CCB). New studies have been added and improvements to the user interface have been introduced. The CDR offers a comprehensive collection of metadata from cohorts and trials across Europe focusing on infectious diseases with epidemic and pandemic potential. The
The CoMeCT project has recently launched a short survey to explore current practices and perspectives on patient engagement in pandemic preparedness. In addition to this, they will be hosting a webinar on 15 April to discuss these topics with patients, researchers and PPI specialists. Patient and public engagement is increasingly recognised as an important component
On Tuesday 16 December, the Cohort Coordination Board (CCB) celebrated its 40th meeting since it’s conception back in April 2022. The CCB, coordinated by the ID-CARE team at the University of Verona, is a forum that brings together cohort-based ID research projects across Europe alongside stakeholder representatives, aiming to facilitate partnerships, find solutions to common challenges
Longitudinal cohort studies, which follow individuals over time, are crucial for understanding disease progression, identifying risk factors, and evaluating public health interventions. END-VOC, one of the European Horizon projects funded during the COVID-19 pandemic, brought together 33 cohorts from 24 countries to study the impact of emerging variants on diagnostics, treatments and vaccines. The project contributed
At the end of September, members of the Cohort Coordination Board (CCB) headed to Rome, Italy, to join colleagues at the VERDI General Assembly and the first in-person workshop of the CCB. The week ended with a collaborative meeting between the CoMeCT and CONTAGIO project teams. VERDI Project General Assembly 2025On 23 and 24 September,
Last month, the second edition of the Cohort Coordination Board (CCB) Activity Report was published, providing a comprehensive overview of the Board’s activities and outputs between 1 January 2024 and 30 April 2025. An overview of the report was presented at the CCB’s first in-person workshop on 22 September in Rome, Italy. The CCB was
Following the 2022 mpox outbreak in Europe and it’s subsequent designation as a Public Health Emergency of International Concern (PHEIC), the Cohort Coordination Board (CCB) performed an extensive mapping of European mpox cohorts as per the VERDI and CoMeCT pandemic preparedness projects. Well-designed cohort studies are crucial for pandemic preparedness informing evidence-based infection prevention and treatment
Earlier this year the CoVICIS project, member of the Cohort Coordination Board, published the final outputs of the COVID Cohorts Policy Insight Series. These resources, listed at the end of this blog, summarise key policy insights from EU-funded COVID cohort consortia, informed by the CoVICIS-led policy project conducted between March 2024 through March 2025. Major
Today marks the launch of the Central Data Repository (CDR), the online database designed to support research pandemic preparedness efforts across Europe. Managed by the Cohort Coordination Board, the CDR offers a comprehensive collection of metadata from cohorts and trials across Europe focusing on infectious diseases with epidemic and pandemic potential. This resource is now publicly accessible
At the end of 2024 the Cohort Coordination Board (CCB) expanded its membership to include cohort studies targeting any infectious disease with epidemic or pandemic potential (IDEPP), welcoming five new cohorts of mpox: ITM Antwerp, MoVIHvax, German Mpox Cohort, VIHMIR, and MPOX-ICONA Cohort. See more information about these five cohorts below. German Mpox CohortThe German